Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2022/137677LIQUID SKIN CLEANSER COMPOSITION
WO 30.06.2022
Int.Class C11D 17/04
CCHEMISTRY; METALLURGY
11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
17Detergent materials or soaps characterised by their shape or physical properties
04combined with or containing other objects
Appl.No PCT/JP2021/034611 Applicant LION CORPORATION Inventor WATABE, Kaori
A liquid skin cleanser composition containing (A) an anionic surfactant, (B) at least one cationic macromolecule selected from dimethyldiallylammonium chloride polymers and dimethyldiallylammonium chloride-acrylic acid copolymers, (C) a long-chain alkyl group-containing quaternary ammonium salt, and (D) at least one selected from dimethicone and dimethiconol. The molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer of component (B) is 40 mol% or more and the mass ratio [{(B) + (C)}]/(A)] of the total content of components (B) and (C) to the content of component (A) is 0.005-0.08.
2.WO/2022/139132ANTIMICROBIAL COMPOSITION AND PREPARATION METHOD THEREFOR, AND PRODUCT THEREOF
WO 30.06.2022
Int.Class A61K 33/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
14Alkali metal chlorides; Alkaline earth metal chlorides
Appl.No PCT/KR2021/013739 Applicant IHN, Dong Chul Inventor IHN, Dong Chul
The present invention relates to an antimicrobial composition and a preparation method therefor, and a product thereof, and, more specifically, to an antimicrobial composition comprising: 50-60 wt% of purified water; 1-10 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), sodium chloride and calcium chloride from among chlorides; 1-2 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), a Pueraria thunbergiana extract and a Platycodon grandiflorus extract from among natural extracts; 5-10 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), sodium carbonate and sodium bicarbonate from among carbonates; 10-15 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), lactic acid and acetic acid from among organic acids, and salts thereof; and 5-10 wt% of a mixture (undiluted solution) comprising chloric-acid-based compounds, which are inorganic acids, and thus the antimicrobial composition ensures the safety of fermentation technology, and increases absorption rate and efficacy in the body so that an excellent antibacterial or antiviral immune enhancement effect can be obtained through the synergistic effect of physiological actions.
3.WO/2022/139582PROCESS FOR CONTROLLED MANUFACTURING OF MONO-DISPERSE MICROBUBBLES
WO 30.06.2022
Int.Class A61K 49/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
49Preparations for testing in vivo
22Echographic preparations; Ultrasound imaging preparations
Appl.No PCT/NL2021/050785 Applicant SOLSTICE PHARMACEUTICALS B.V. Inventor DE VARGAS SERRANO, Miguel
The present invention relates to a process for preparing a hydrated phospholipids solvent mixture, by: - dissolving a first phospholipid at a temperature above the phase transition temperature of the phospholipids in an organic solvent to form a dissolved phospholipid solvent mixture; - dissolving a second phospholipid at a temperature above the phase transition temperature of the phospholipids in the dissolved phospholipid solvent mixture to form a dissolved phospholipids solvent mixture; - adding an aqueous phosphate buffer to the dissolved phospholipids solvent mixture to form a buffered phospholipids solvent mixture; and - stirring the buffered phospholipids solvent mixture to form a hydrated phospholipids solvent mixture.
4.WO/2022/139732DEVELOPMENT OF NANOMATERIAL FOR CONTROLLED RELEASE OF LUTEOLIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
WO 30.06.2022
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No PCT/TR2021/051173 Applicant EGE ÜNİVERSİTESİ Inventor AKGÖL, Sinan
The invention relates to the development of nanomaterials for the controlled release of luteolin used in the treatment of neurodegenerative diseases.
5.WO/2022/139747SOLUTION PROVIDED WITH ANTIMICROBIAL PROPERTY AND SKIN PRODUCT MANUFACTURED FROM THE PRODUCT TO WHICH SAID SOLUTION IS APPLIED
WO 30.06.2022
Int.Class A61K 8/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
02characterised by special physical form
Appl.No PCT/TR2021/051265 Applicant ECZACIBASI TUKETIM URUNLERI SANAYI VE TICARET ANONIM SIRKETI Inventor FIDANLIK, Gulcin Almina
The subject of the invention relates to a solution provided with antimicrobial property, a nonwoven fabric provided with antimicrobial property to which said solution is applied, a skin product manufactured from said fabric and a method for applying said solution to the fabric. The solutions developed within the scope of the invention comprise at least one active ingredient at a ratio of 0.05-0.2% by weight and water at a ratio of 99.8-99.95% by weight, depending on the quantity of active ingredient used.
6.WO/2022/139372METHOD FOR PREPARING AGENT FOR PREVENTION OF HAIR LOSS AND PROMOTION OF HAIR REGROWTH THROUGH FUSION FERMENTATION OF LACTIC ACID BACTERIA
WO 30.06.2022
Int.Class A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Appl.No PCT/KR2021/019416 Applicant KUNYOUNG ENC. CO., LTD. Inventor LEE, Chae Kun
The present invention is characterized by implementation of a method for preparing an agent for prevention of hair loss and promotion of hair regrowth wherein aerobic lactic acid bacteria and anaerobic lactic acid bacteria are fermented in a fusion manner to repeat a cycle of fermentation, degradation, and synthesis whereby the prevention of hair loss and the promotion of hair regrowth are achieved through the fused fermentation process of lactic acid bacteria.
7.WO/2022/139477NOVEL USE OF ARTEMISIA ANNUA EXTRACT
WO 30.06.2022
Int.Class A61K 36/282
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
282Artemisia, e.g. wormwood or sagebrush
Appl.No PCT/KR2021/019643 Applicant UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY Inventor CHOI, Jung Hye
The present invention provides a medicinal and/or culinary use of an Artemisia annua extract for treating, ameliorating and/or preventing at least one selected from among bone diseases, menopausal disorders, cardiovascular diseases, neurodegenerative diseases, and obesity. The present invention has the advantage of having little or no possibility of side effects such as cancer, and being capable of effectively treating, ameliorating and/or preventing at least one selected from among bone diseases, menopausal disorders, cardiovascular diseases, neurodegenerative diseases, and obesity.
8.WO/2022/139537POLYPEPTIDE SPECIFIC FOR MUCIN 1 AND USE THEREOF
WO 30.06.2022
Int.Class C07K 16/30
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
30from tumour cells
Appl.No PCT/KR2021/019790 Applicant LG CHEM, LTD. Inventor LEE, Ji Hyun
The present invention relates to a polypeptide binding to mucin 1, an isolated polynucleotide encoding same, a vector carrying the polynucleotide, and a cell including the vector. In addition, the present invention relates to a chimeric antigen receptor including the polypeptide binding to mucin 1, an isolated polynucleotide encoding the chimeric antigen receptor, a vector carrying the polynucleotide, an immune cell expressing the chimeric antigen receptor, a composition comprising same for treatment of cancer, and a method for treatment of cancer.
9.WO/2022/139552COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME
WO 30.06.2022
Int.Class A61K 38/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
26Glucagons
Appl.No PCT/KR2021/019854 Applicant HANMI PHARM. CO., LTD. Inventor CHOI, Jae Hyuk
The present invention relates to a combination therapy of insulinotropic peptide and GLP-2, for preventing, alleviating or treating short bowel syndrome.
10.WO/2022/140467TOPICAL COMPOSITIONS AND METHODS OF TREATING SKIN DISEASES AND CONDITIONS WITH SUCH COMPOSITIONS
WO 30.06.2022
Int.Class A61K 31/192
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Appl.No PCT/US2021/064729 Applicant SAMSON PHARMA, LLC Inventor DURRANI, Manzer J.
A pharmaceutical composition is provided including tamibarotene or a salt or analog thereof, a solubilizer, a permeation enhancer, a polymeric emulsifier, and a surfactant. In a further preferred embodiment, the pharmaceutical composition is in the form of a gel or cream, and provides a smooth composition to apply to the skin. The invention is further directed to methods of manufacturing the pharmaceutical composition and methods of treating a patient's skin with the pharmaceutical composition.